Globe Life (NYSE:GL) Announces Earnings Results

Globe Life (NYSE:GLGet Free Report) announced its quarterly earnings results on Wednesday. The company reported $3.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.06 by $0.43, Yahoo Finance reports. The firm had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.46 billion. Globe Life had a return on equity of 21.93% and a net margin of 18.47%. The firm’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.71 EPS.

Globe Life Price Performance

Shares of GL traded down $4.74 during mid-day trading on Friday, hitting $104.65. The company’s stock had a trading volume of 632,206 shares, compared to its average volume of 1,594,859. The stock has a market capitalization of $9.40 billion, a price-to-earnings ratio of 9.48 and a beta of 0.81. Globe Life has a fifty-two week low of $38.95 and a fifty-two week high of $132.00. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.05 and a quick ratio of 0.05. The firm has a 50-day moving average price of $105.21 and a 200 day moving average price of $90.90.

Globe Life Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Friday, October 4th will be paid a dividend of $0.24 per share. The ex-dividend date is Friday, October 4th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.92%. Globe Life’s dividend payout ratio is presently 8.68%.

Analyst Upgrades and Downgrades

GL has been the topic of a number of analyst reports. Truist Financial lifted their target price on Globe Life from $90.00 to $105.00 and gave the stock a “hold” rating in a research report on Friday. Piper Sandler raised their price objective on shares of Globe Life from $118.00 to $130.00 and gave the stock an “overweight” rating in a report on Friday. Raymond James increased their price target on shares of Globe Life from $160.00 to $188.00 and gave the stock a “strong-buy” rating in a research report on Tuesday, October 15th. Keefe, Bruyette & Woods restated an “outperform” rating and set a $118.00 price objective (up previously from $110.00) on shares of Globe Life in a research note on Wednesday, July 31st. Finally, Wells Fargo & Company lifted their target price on Globe Life from $108.00 to $117.00 and gave the stock an “overweight” rating in a research report on Thursday, October 10th. Five investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Globe Life presently has an average rating of “Moderate Buy” and a consensus price target of $123.80.

View Our Latest Analysis on GL

About Globe Life

(Get Free Report)

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

See Also

Earnings History for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.